Literature DB >> 26418028

Assessment of Nutritional Status in Children With Cancer and Effectiveness of Oral Nutritional Supplements.

Dilek Gürlek Gökçebay1, Suna Emir1, Turan Bayhan1, Hacı Ahmet Demir1, Mehmet Gunduz2, Bahattin Tunc3.   

Abstract

Malnutrition is a common consequence of cancer in children, but the most effective methods of nutrition intervention are under debate. We aimed to evaluate the nutritional status of children diagnosed with cancer, and to investigate the effect of oral nutritional supplements on anthropometric measurements, biochemical parameters, and outcome. A randomized clinical study of 45 newly diagnosed cancer patients was performed. Anthropometric and biochemical data and related factors were assessed at 0, 3, and 6 months after diagnosis. On initial anthropometric assessment, prevalence of malnutrition by weight or height was found to be lower as compared with body mass index (BMI), or weight for height (WFH), or arm anthropometry. Twenty-six of the patients (55%) received oral nutritional supplement. During the second 3 months after diagnosis, there was a statistically significant decrease in number of the patients with WFH <90th percentile and BMI <5th percentile (P = .003 and P = .04, respectively). Infectious complications occurred more frequently in malnourished patients during first 3 months, and survival of children who were malnourished at the 6th month was significantly lower than that of well-nourished children (P = .003). On laboratory assessment, serum prealbumin levels of the all subjects were below normal ranges, but no relation was found for serum prealbumin or albumin levels in patients who were malnourished or not at diagnosis. Nutritional intervention is necessary to promote normal development and increase functional status as a child receives intensive treatment. Protein- and energy-dense oral nutritional supplements are effective for preventing weight loss in malnourished children.

Entities:  

Keywords:  cancer; children; malnutrition; nutritional status

Mesh:

Year:  2015        PMID: 26418028     DOI: 10.3109/08880018.2015.1065303

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

1.  Malnutrition in paediatric patients with leukaemia and lymphoma: a retrospective cohort study.

Authors:  Hardenson Rodríguez González; Sergio Andrade Mejía; Javier Orlando Contreras Ortiz; Adriana Patricia Osorno Gutiérrez; Jorge Eliécer Botero López; Javier Enrique Fox Quintana
Journal:  Ecancermedicalscience       Date:  2021-12-02

2.  Serum prealbumin as an effective prognostic indicator for determining clinical status and prognosis in patients with hemorrhagic stroke.

Authors:  Shen-Qi Zhang; Bin Peng; Creed M Stary; Zhi-Hong Jian; Xiao-Xing Xiong; Qian-Xue Chen
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

3.  Energy-dense, low-volume paediatric oral nutritional supplements improve total nutrient intake and increase growth in paediatric patients requiring nutritional support: results of a randomised controlled pilot trial.

Authors:  Gary P Hubbard; Catherine Fry; Katy Sorensen; Catherine Casewell; Lydia Collins; Annaruby Cunjamalay; Michelle Simpson; Amanda Wall; Elmarie Van Wyk; Matthew Ward; Sophie Hallowes; Hannah Duggan; Jennifer Robison; Helen Gane; Lucy Pope; Jennifer Clark; Rebecca J Stratton
Journal:  Eur J Pediatr       Date:  2020-03-13       Impact factor: 3.183

4.  Nutrition education and cooking workshops for families of children with cancer: a feasibility study.

Authors:  S Beaulieu-Gagnon; V Bélanger; C Meloche; D Curnier; S Sultan; C Laverdière; D Sinnett; V Marcil
Journal:  BMC Nutr       Date:  2019-11-19

5.  Perspective: Creating the Evidence Base for Nutritional Support in Childhood Cancer in Low- and Middle-Income Countries: Priorities for Body Composition Research.

Authors:  Alexia J Murphy-Alford; Maya Prasad; Jeremy Slone; Katja Stein; Terezie T Mosby
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.